Global Certificate Course in Biotechnology in Antibody Therapeutics

-- viewing now

The Global Certificate Course in Biotechnology in Antibody Therapeutics is a comprehensive program designed to equip learners with essential skills in the rapidly growing field of antibody therapeutics. This course is crucial in the current industry landscape, where antibody therapeutics are becoming increasingly important in treating various diseases, including cancer and autoimmune disorders.

4.0
Based on 5,960 reviews

7,763+

Students enrolled

GBP £ 140

GBP £ 202

Save 44% with our special offer

Start Now

About this course

This course covers the latest advancements and best practices in antibody engineering, production, and clinical development. Learners will gain hands-on experience with cutting-edge technologies and techniques used in the industry, such as phage display, hybridoma technology, and antibody-drug conjugates. By the end of the course, learners will have a deep understanding of the regulatory and ethical considerations in antibody therapeutics development. This course is ideal for professionals looking to advance their careers in biotechnology, pharmaceuticals, or research institutions. By completing this program, learners will be well-positioned to take on leadership roles in antibody therapeutics development and contribute to the development of life-saving treatments for patients worldwide.

100% online

Learn from anywhere

Shareable certificate

Add to your LinkedIn profile

2 months to complete

at 2-3 hours a week

Start anytime

No waiting period

Course details

Introduction to Biotechnology in Antibody Therapeutics: Overview of biotechnology and its applications in antibody therapeutics, including history, principles, and current trends.
Antibody Structure and Function: Detailed examination of antibody structure, including heavy and light chains, variable and constant regions, and antibody-antigen interactions. Also covers antibody functions such as neutralization, complement fixation, and antibody-dependent cellular cytotoxicity.
Monoclonal Antibodies: Production and Applications: Covers the production of monoclonal antibodies, including hybridoma technology, recombinant DNA technology, and phage display. Also covers the applications of monoclonal antibodies in diagnosis, therapy, and research.
Antibody Engineering and Humanization: Examines the techniques used to engineer antibodies, including affinity maturation, Fc engineering, and humanization. Discusses the advantages and disadvantages of different approaches and their applications in therapy.
Therapeutic Antibodies: Mechanisms of Action: Discusses the mechanisms of action of therapeutic antibodies, including direct and indirect effects. Covers topics such as receptor binding, signal transduction, and immune effector functions.
Clinical Development of Antibody Therapeutics: Covers the clinical development of antibody therapeutics, including preclinical studies, clinical trial design, and regulatory considerations. Discusses the challenges and opportunities in developing antibody therapeutics.
Emerging Trends in Antibody Therapeutics: Explores emerging trends in antibody therapeutics, including bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors. Discusses the potential of these approaches to transform the field of cancer therapy.
Challenges and Limitations of Antibody Therapeutics: Examines the challenges and limitations of antibody therapeutics, including issues such as

Career path

Entry requirements

  • Basic understanding of the subject matter
  • Proficiency in English language
  • Computer and internet access
  • Basic computer skills
  • Dedication to complete the course

No prior formal qualifications required. Course designed for accessibility.

Course status

This course provides practical knowledge and skills for professional development. It is:

  • Not accredited by a recognized body
  • Not regulated by an authorized institution
  • Complementary to formal qualifications

You'll receive a certificate of completion upon successfully finishing the course.

Why people choose us for their career

Loading reviews...

Frequently Asked Questions

What makes this course unique compared to others?

How long does it take to complete the course?

What support will I receive during the course?

Is the certificate recognized internationally?

What career opportunities will this course open up?

When can I start the course?

What is the course format and learning approach?

Course fee

MOST POPULAR
Fast Track GBP £140
Complete in 1 month
Accelerated Learning Path
  • 3-4 hours per week
  • Early certificate delivery
  • Open enrollment - start anytime
Start Now
Standard Mode GBP £90
Complete in 2 months
Flexible Learning Pace
  • 2-3 hours per week
  • Regular certificate delivery
  • Open enrollment - start anytime
Start Now
What's included in both plans:
  • Full course access
  • Digital certificate
  • Course materials
All-Inclusive Pricing • No hidden fees or additional costs

Get course information

We'll send you detailed course information

Pay as a company

Request an invoice for your company to pay for this course.

Pay by Invoice

Earn a career certificate

Sample Certificate Background
GLOBAL CERTIFICATE COURSE IN BIOTECHNOLOGY IN ANTIBODY THERAPEUTICS
is awarded to
Learner Name
who has completed a programme at
London School of International Business (LSIB)
Awarded on
05 May 2025
Blockchain Id: s-1-a-2-m-3-p-4-l-5-e
Add this credential to your LinkedIn profile, resume, or CV. Share it on social media and in your performance review.
SSB Logo

4.8
New Enrollment